USPTO 2015–2025 USPTO PatentsView US Corporation

BONE FOAM, Inc.

USPTO PatentsView assignee record - 27 granted patents across 4 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61G (TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS ; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES).

27
Total patents granted
4
CPC technology areas
10.0
Avg claims per patent
+1150%
5-year filing velocity

The verdict

BONE holds 27 US patents across 4 technology areas, rank #11,181 of 50,000 tracked assignees.

#11,181
of 50,000 US assignees by volume
Top 25%
by Innovation Score (44.6/100)
10.0
avg claims per patent
+1150%
filing velocity, last 5 yrs

Portfolio overview

BONE FOAM, INC. has been granted 27 US utility patents between 2016 and 2025, placing BONE FOAM, INC. at rank #11,181 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.0 claims per patent with primary concentration in A61G (TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS ; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES). As a US Corporation, BONE FOAM, INC. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 44.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 25 grants, compared with 2 in the 2015–2019 window, a +1150% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. BONE FOAM, INC.'s 10.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark BONE FOAM, INC. against peers pursuing similar technology classes.

How does BONE compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows BONE holds 27 patents, placing it at rank #11,181 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

BONE's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

45 Top 25% higher than 75% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

0246810 20162019202020212022202320242025 3
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
BONE FOAM, INC. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 3.7%
2019 1 3.7%
2020 1 3.7%
2021 2 7.4%
2022 8 29.6%
2023 7 25.9%
2024 4 14.8%
2025 3 11.1%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple
Velocity Accelerating

Where it ranks

Overall rank by patents

#11,181

Across all tracked assignees

Innovation Score

44.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does BONE FOAM, INC. hold?
BONE FOAM, INC. holds 27 US granted patents filed between 2016 and 2025, spanning 4 technology areas.
What is BONE FOAM, INC.'s Innovation Score?
BONE FOAM, INC. has an Innovation Score of 44.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does BONE FOAM, INC. focus on?
BONE FOAM, INC.'s top technology area is A61G (TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS ; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES) with 11 patents. The company has filed patents in 4 CPC subclasses total.
Is BONE FOAM, INC.'s patent filing rate increasing or decreasing?
BONE FOAM, INC.'s recent filing velocity is +1150% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for BONE FOAM, INC.'s patents?
BONE FOAM, INC.'s patents average 10.0 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the BONE FOAM, INC. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

BONE's 27 grants land it in the top 25% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - BONE ranks #11,181 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61G - see who else leads that technology area. A61G leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov